Blood test could help doctors choose the right drug for deadly sepsis
NCT ID NCT05824767
Summary
This small, completed pilot study tested whether two substances in the blood (renin and DPP3) can predict which patients with severe septic shock will respond better to a drug called angiotensin II versus standard vasopressor therapy. The goal was to gather information to design a larger future trial, not to prove one treatment is better than the other. Researchers compared the two treatments in 40 adult patients whose blood pressure remained dangerously low despite initial medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, 87106, United States
Conditions
Explore the condition pages connected to this study.